Merck & Co., Inc. - Significant Ownership

Signature - Title
Kelly E. W. Grez - Corporate Secretary
Location
Kenilworth, NJ
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Merck & Co., Inc..

Significant Ownership of Merck & Co., Inc.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
EVAX Evaxion Biotech A/S American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share 19.96% $56.7M 63M Merck & Co., Inc. Jan 31, 2025
PSNL Personalis, Inc. Common Stock, $0.0001 par value per share 16.5% $50.4M 14M Merck & Co., Inc. Dec 19, 2024

Schedules 13D/G Reported by Merck & Co., Inc.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.